Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:45:44 UTC, with 27 holding rows worth $1,051,599,250.

Accession
0001744967-26-000014
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 27 entries on the cover page, a total value of $1,051,599,250 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,051,599,250 with VALUE read as dollars as filed, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SCHOLAR ROCK HLDG CORP80706P103COM6,897,652$333,294,545dollars as filed
MINERALYS THERAPEUTICS INC603170101COM5,871,018$147,538,682dollars as filed
SEPTERNA INC COM81734D104Stock3,066,453$119,990,306dollars as filed
ALAMAR BIOSCIENCES INC010911105COMMON STOCK2,480,310$84,504,162dollars as filed
SPYGLASS PHARMA INC85220G109COMMON STOCK2,109,953$54,858,778dollars as filed
ALUMIS INC022307102COM7,235,809$53,472,629dollars as filed
NEUROGENE INC64135M105COMMON STOCK1,867,127$51,943,473dollars as filed
KALARIS THERAPEUTICS INC482929106COM12,881,175$37,226,596dollars as filed
INVENTIVA SA46124U107ADS6,314,805$23,301,630dollars as filed
PARABILIS MEDICINES INC COM698955101Stock556,044$17,954,661dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK1,062,872$17,122,868dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM7,240,000$12,090,800dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share837,173$11,494,385dollars as filed
AQUESTIVE THERAPEUTICS INC COM03843E104Stock2,434,367$11,271,119dollars as filed
VTV THERAPEUTICS INC918385204CL A NEW354,730$10,939,873dollars as filed
JADE BIOSCIENCES INC008064206COM NEW736,237$10,344,130dollars as filed
NKARTA INC65487U108COMMON STOCK3,507,666$9,190,085dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN10,369,159$8,202,005dollars as filed
ARTIVA BIOTHERAPEUTICS INC04317A107COM954,861$6,798,610dollars as filed
AGOMAB THERAPEUTICS NV00860C102SPONSORED ADS594,749$6,601,714dollars as filed
ELOXX PHARMACEUTICALS INC29014R301COM NEW400,000$6,124,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS55,095$5,455,507dollars as filed
COHERUS ONCOLOGY INC19249H103COM3,383,565$4,094,114dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK1,347,723$3,908,397dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK300,361$1,582,902dollars as filed
TCGX ACQUISITION CORPG8708J109COM100,000$1,251,000dollars as filed
Gossamer Bio, Inc.38341P201Common Stock, $0.0001 par value per share87,956$1,042,279dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001744967-26-000014this filing2026-11-16